Trial intelligence / Profile preview

Cariprazine in schizophrenia

NCT00862992Phase 2Completed

Sponsor
Mitsubishi Tanabe Pharma
Start
Apr 2008
Primary completion
Sep 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of cariprazine in schizophrenia, sponsored by Mitsubishi Tanabe Pharma. Started Apr 2008; status: completed.

02

Drugs

cariprazine
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00862992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00862992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call